In xenograft models of human KRAS‐mt HCT‐116 cells, the knockout of β4 subunit did not alter the tumor growth rate, but reduced the extent of metastatic foci in the lungs, although no effect was observed in liver metastases. The gene discussed is KRAS; the disease is neoplasm.